Laurence Marton

CIK: 0001862192

Transaction Breakdown

Open Market Buys (P)2 (28.6%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (14.3%)

Derivative conversions

Awards (A)4 (57.1%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

RNXT

RenovoRx, Inc.

Director

NONE

Matternet, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

RNXT
RenovoRx, Inc.
Oct 1, 2026
Award(A)
Stock Options (right to buy)
Direct
55.9K shares-
No ticker
Matternet, Inc.
May 22, 2026
Award(A)
Direct
52K shares-
RNXT
RenovoRx, Inc.
Mar 20, 2026
Purchase(P)
Indirect
9.7K shares-
RNXT
RenovoRx, Inc.
Oct 1, 2025
Award(A)
Stock Options (right to buy)
Direct
47.6K shares-
RNXT
RenovoRx, Inc.
May 2, 2025
Exercise(M)
Direct
20.5K shares at avg. $0.15$3K
RNXT
RenovoRx, Inc.
Apr 8, 2025
Purchase(P)
Direct
12.1K shares at avg. $0.85$10K
RNXT
RenovoRx, Inc.
Oct 1, 2024
Award(A)
Stock Options (right to buy)
Direct
25.1K shares-

		Type	Shares	Price		Ownership
Oct 1, 2026	RNXT RenovoRx, Inc.	Award(A) Stock Options (right to buy)	55,924	-	-	Direct
May 22, 2026	No ticker Matternet, Inc.	Award(A)	52,003	-	$0	Direct
Mar 20, 2026	RNXT RenovoRx, Inc.	Purchase(P)	9,720	-	$0	Indirect
Oct 1, 2025	RNXT RenovoRx, Inc.	Award(A) Stock Options (right to buy)	47,640	-	-	Direct
May 2, 2025	RNXT RenovoRx, Inc.	Exercise(M)	20,480	$0.15	$3,072	Direct
Apr 8, 2025	RNXT RenovoRx, Inc.	Purchase(P)	12,050	$0.85	$10,218	Direct
Oct 1, 2024	RNXT RenovoRx, Inc.	Award(A) Stock Options (right to buy)	25,099	-	-	Direct

1-7 of 7 transactions

About Marton Laurence

Marton Laurence (SEC CIK 0001862192) files insider reports with the SEC as Director of RenovoRx, Inc. (RNXT) and Director of Matternet, Inc.

Signal8 holds 8 ownership filings by Marton Laurence (1 Form 3, 7 Form 4), filed between Oct 2, 2024 and Oct 2, 2026. Those filings report 7 transactions, from Oct 1, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Marton Laurence's filings is in MOUNTAIN VIEW, CA.

Recent filings by Marton Laurence

Oct 1, 2026: Grant or award of RNXT derivative securities (Form 4, code A).
May 22, 2026: Grant or award of Matternet, Inc. shares (Form 4, code A).
Mar 20, 2026: Open-market purchase of RNXT shares (Form 4, code P).
Oct 1, 2025: Grant or award of RNXT derivative securities (Form 4, code A).
May 2, 2025: Option exercise of RNXT shares (Form 4, code M).

Other insiders filing for RenovoRx, Inc. (RNXT)

Macfarlane K. Angela, Director
Spiegel Robert J., Director
RYAN UNA S, Director
VOLL MARK, Chief Financial Officer
Bagai Shaun, Chief Executive Officer
Gentry Leesa, Chief Clinical Officer

How to read Form 4 transaction codes